37.85CHF+0.40%Mkt Cap: 1.25B CHFP/E: —Last update: 2026-05-13
PolyPeptide Group AG operates as a contract development and manufacturing company in Europe, the United States, Asia Pacific, and internationally. It develops and manufactures synthetic peptides used as active pharmaceut…
Industry Peers
Drug Manufacturers - Specialty & Generic153.14BSEKP/E 167.7
58.14BTRYP/E 27.8
51.02BEURP/E 20.1
13.68BEURP/E 31.2
13.35BTRY—
13.10BSEKP/E 39.5
3.09BTRY—
3.02BEURP/E 25.0
loading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)—
P/E (Forward)33.00
PEG—
P/B3.91
P/S3.17
EV/EBITDA34.11
EV/Revenue3.34
EPS (TTM)-0.59
EPS (Forward)1.13
Cash Flow & Leverage
FCF Yield-3.51%
FCF Margin-11.25%
Operating CF77.51M CHF
CapEx (TTM)108.91M CHF
Net Debt/EBITDA1.75
Net Debt66.77M CHF
Technical
SMA 5031.40 (+20.5%)
SMA 20027.07 (+39.8%)
Beta1.02
S&P 52W Chg24.23%
Avg Vol (30d)100.46K
Avg Vol (10d)86.23K
Technical Indicators
RSI (14)60.3
MACD2.1593
MACD Signal2.4319
MACD Hist.-0.2725
BB Upper41.21 CHF
BB Middle37.26 CHF
BB Lower33.30 CHF
BB Width21.23%
ATR (14)1.628 CHF
Vol Ratio (20d)0.71x
52W Range
18.2084% of range41.70
52W High41.70 CHF
52W Low18.20 CHF
Profitability
Gross Margin16.98%
EBITDA Margin9.78%
Profit Margin-5.40%
Oper. Margin9.99%
ROE-6.22%
ROA-2.56%
Revenue Growth10.20%
Earnings Growth—
Balance Sheet
Debt/Equity0.38
Current Ratio1.74
Quick Ratio0.87
Book Value/Sh9.541 CHF
Cash/Share2.260 CHF
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CHF
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateApr 28, 2022
Pay DateMay 2, 2022
Ownership
Shares Out.33.01M
Float12.96M
Insiders60.52%
Institutions20.26%
Analyst Consensus
Rating1.8 (Buy)
Target (Mean)35.75 CHF
Target Range25.31 CHF – 43.62 CHF
# Analysts6
Company
Market Cap1.25B CHF
Enterprise Value1.30B CHF
Revenue (TTM)389.33M CHF
Gross Profit66.53M CHF
Net Income (TTM)-21.17M CHF
Revenue/Share11.80 CHF
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees1.4K
Last Price37.85 CHF
CountryCH
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—